C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/1999
11/04/1999	WO1999042090A3 Treating cancer
11/04/1999	WO1999037788A9 Diagnosis and treatment of aur1 and/or aur2 related disorders
11/04/1999	WO1999037775A3 Compositions and methods for detecting and treating breast cancer
11/04/1999	WO1999036545A3 Adenoviral vectors with modified capsid proteins
11/04/1999	WO1999036536A9 Methods and compositions to alter tissue susceptibility to immune injury, to programmed cell death, and to clearance by the reticuloendothelial system
11/04/1999	WO1999034819A3 Use of citrulline peptides derived from filaggrin for treating autoimmune diseases
11/04/1999	WO1999034004A3 Metastatic breast and colon cancer regulated genes
11/04/1999	WO1999033981A3 Human signal peptide-containing proteins
11/04/1999	WO1999029865A9 A protein belonging to the tnf superfamily, nucleic acids encoding same, and methods of use thereof
11/04/1999	WO1999029724A9 Dna encoding pasteurella multocida outer membrane protein
11/04/1999	WO1999019481A3 Mammalian genes involved in viral infection and tumor suppression
11/04/1999	WO1998027113A9 Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5
11/04/1999	WO1997049812A3 Process for extracting and purifying recombinant, non-lipidised osp-protein
11/04/1999	DE19820190A1 Menschliche Nukleinsäuresequenzen aus Pankreas-Tumor Human nucleic acid sequences from pancreatic tumor
11/04/1999	CA2565375A1 Polyol-ifn-beta conjugates
11/04/1999	CA2330560A1 Methods for transducing fusion molecules
11/04/1999	CA2330086A1 Chimeras of hepatitis c virus and bovine viral diarrhea virus
11/04/1999	CA2330038A1 Compositions and methods for identifying apoptosis signaling pathway inhibitors and activators
11/04/1999	CA2329908A1 Targeted gene delivery to cells by filamentous bacteriophage
11/04/1999	CA2328992A1 Nr-cam gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors
11/04/1999	CA2327551A1 Secreted proteins and polynucleotides encoding them
11/04/1999	CA2327504A1 Cd40-interacting and traf-interacting proteins
11/04/1999	CA2327456A1 Nucleic acids of the m antigen gene of histoplasma capsulatum, antigens, vaccines and antibodies, methods and kits for detecting histoplasmosis
11/04/1999	CA2327381A1 Human proteins having transmembrane domains and dnas encoding these proteins
11/04/1999	CA2327317A1 Polynucleotides isolated from skin cells and methods for their use
11/04/1999	CA2327178A1 Host-encoded protein expressed on marek's disease (mdv)-infected cells and antibody thereto
11/04/1999	CA2327176A1 Methods for modulating differentiation
11/04/1999	CA2326820A1 Polypeptides from moraxella (branhamella) catarrhalis
11/04/1999	CA2326757A1 Regulation of biofilm formation
11/04/1999	CA2326755A1 G-csf receptor agonist antibodies and screening method therefor
11/04/1999	CA2326627A1 Nucleotide sequences for detecting enterohemorrhagic escherichia coli (ehec)
11/04/1999	CA2326601A1 Ese genes and proteins
11/04/1999	CA2326404A1 Basb013 dna and proteins from neisseria meningitidis
11/04/1999	CA2326377A1 Internalizing erbb2 antibodies
11/04/1999	CA2326376A1 Polyepitope carrier protein
11/04/1999	CA2326375A1 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
11/04/1999	CA2326233A1 Delayed rectifier potassium channel subunit
11/04/1999	CA2326001A1 Fizz proteins
11/04/1999	CA2325869A1 A novel g-protein coupled receptor
11/04/1999	CA2325055A1 Vaccines containing recombinant pilin against neisseria gonorrhoeae or neisseria meningitidis
11/04/1999	CA2295105A1 Generation of packaging system for human recombinant adenoviral vectors
11/04/1999	CA2294618A1 Anti-vibrio anguillarum vaccine (gava-3) for the prevention of the vibriosis disease in the turbot and salmonidae, and preparation process
11/03/1999	EP0953835A1 Apparatus for detection of a fluorescence pattern corresponding to ligand binding on a substrate
11/03/1999	EP0953650A1 Method for typing of HLA alleles
11/03/1999	EP0953648A2 Viral defective vaccine produced by transcomplementing cell line
11/03/1999	EP0953646A2 Herbicide tolerant transgenic plants where the herbicide inhibits prophyrin biosynthesis
11/03/1999	EP0953645A2 Transcription factor controlling phenylpropanoid biosynthesis pathway
11/03/1999	EP0953642A1 Antigenic protein originating in infectious laryngotracheitis virus
11/03/1999	EP0953641A2 Polynucleotide molecules encoding neospora proteins
11/03/1999	EP0953640A2 cDNA sequences of genes involved in the induction of resistance in plants
11/03/1999	EP0953638A1 Human vanilloid receptor-like cation channel
11/03/1999	EP0953637A2 Acetylcholine receptor
11/03/1999	EP0953636A2 Cytokine signal regulators
11/03/1999	EP0953577A1 Procedure for obtaining the somatostatin analog, octreotide
11/03/1999	EP0953576A1 Active hedgehog protein conjugate, process for its production and use
11/03/1999	EP0953575A1 Active hedgehog protein conjugate, process for its production and use
11/03/1999	EP0953574A1 Immunodiagnostic reagent for the detection of Maedi-Visna virus and CAEV infection
11/03/1999	EP0953572A2 Peptides binding to bone marrow stromal cell antigen
11/03/1999	EP0953153A1 Novel method of diagnosing and treating gliomas
11/03/1999	EP0953053A2 Viral particles which are masked or unmasked with respect to a cell receptor
11/03/1999	EP0953051A1 Use of chemokine antagonist molecules for their antiviral activity, particularly against an hiv type retrovirus
11/03/1999	EP0953049A2 Novel human metallothionein
11/03/1999	EP0953048A1 Compounds for modulating cell negative regulations and biological applications thereof
11/03/1999	EP0953047A2 VACCINE CONTAINING A PEROXIREDOXIN AND/OR A beta-TUBULIN
11/03/1999	EP0953046A1 Human hematopoietic stem and progenitor cell antigen and methods for its use
11/03/1999	EP0953044A2 Gene for adenylate cyclase and its use
11/03/1999	EP0953043A1 Genes and gene products related to werner's syndrome
11/03/1999	EP0953042A1 Methods and reagents for regulating telomere length and telomerase activity
11/03/1999	EP0953041A1 Serum-free mammalian cell culture medium, and uses thereof
11/03/1999	EP0953038A1 Novel process for the propagation of b. pertussis
11/03/1999	EP0952987A2 Antibodies against epitopes, exposed on surfaces of cancer cells outside desmosomes, of desmosomal cadherines
11/03/1999	EP0952986A1 Antimicrobially active polypeptides
11/03/1999	EP0952985A1 Broad spectrum pyrogenic exotoxins antagonists and vaccines
11/03/1999	EP0952984A1 Two-component signal tranducing system from staphylococcus aureus
11/03/1999	EP0952983A2 Unique dendritic cell-associated c-type lectins, dectin-1 and dectin-2; compositions and uses thereof
11/03/1999	EP0952982A2 Novel hepatitis b inhibitors
11/03/1999	EP0952981A1 Method for producing a correctly folded, biological active recombinant protein
11/03/1999	EP0952980A1 Acyl transfer with stabilised transition complex using catalyst with catalytic imidazole (e.g. histidine) function
11/03/1999	EP0952846A1 Prolactin as a vaccine adjuvant
11/03/1999	EP0952845A1 Treatment of mammalian myocardium with morphogen locally, or with morphogenically-treated myogenic precursor cells
11/03/1999	EP0952844A1 USE OF PROTEIN S-100b IN MEDICINES AND MEDICINES CONTAINING THE PROTEIN S-100b
11/03/1999	EP0952767A1 Production of somatic mosaicism in mammals using a recombinatorial substrate
11/03/1999	EP0853484A4 Novel mu opioid receptor ligands: agonists and antagonists
11/03/1999	EP0773992A4 Transgenically produced antithrombin iii
11/03/1999	EP0737314A4 Novel uses for gal4-receptor constructs
11/03/1999	EP0737073A4 Novel peptides for heparin and low molecular weight heparin anticoagulation reversal
11/03/1999	EP0371998B2 Modular assembly of antibody genes, antibodies prepared thereby and use
11/03/1999	CN1234078A Compositions and method for treating viral infections
11/03/1999	CN1234077A Structural and functional conservation of C. Elegans clock gene clk-1
11/03/1999	CN1234073A Circularly permuted erythropoietin receptor agonists
11/03/1999	CN1234071A Keratinocyte grouth factor -2(KGF-2 or fibroblast growth factor-12, FGF-12)
11/03/1999	CN1233938A Pesticidal agent
11/03/1999	CN1233616A Active hedgehog protein conjugate, process for its prodn. and use
11/02/1999	US5977441 Transgenic plants that have been modified such that expression of a desired introduced gene can be limited to a particular stage of plant development, a particular plant tissue, particular environmental conditions, or a particular time or
11/02/1999	US5977438 Production of peptides in plants as viral coat protein fusions
11/02/1999	US5977436 Nucleic acid which directs seed-specific expression of linked heterologous nucleic acid; for expression cassettes and vectors to modulate fatty acid synthesis or lipid metabolism in transformed plants
11/02/1999	US5977434 The nucleic acids can be used to produce transgenic plants resistant to the pathogen.
11/02/1999	US5977343 One pot deprotection by contacting protected base with anhydrous methyl amine and contacting protected 2'hydroxyl group with triethylamine*3 hydrogen fluoride; high yield with high biological activity
11/02/1999	US5977338 Polynucleotides which hybridize with naturally occurring sequences encoding human interferon-inducible protein (hifi) and the polynucleotides which identify and encode hifi.
11/02/1999	US5977337 The nucleic acid molecule may be used in the diagnosis of infection.

1 ... 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 2245 2246 2247 2248 2249 ... 2916